We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$330M
AUM Growth
+$51.5M
Cap. Flow
+$20M
Cap. Flow %
6.05%
Top 10 Hldgs %
42.1%
Holding
100
New
10
Increased
21
Reduced
16
Closed
3

Top Sells

Rank Stock Value
1
HWM icon
Howmet Aerospace
HWM
+$3.47M
2
SYK icon
Stryker
SYK
+$3.09M
3
TSLA icon
Tesla
TSLA
+$440K
4
IBB icon
iShares Biotechnology ETF
IBB
+$82.7K
5
EOG icon
EOG Resources
EOG
+$59.6K

Sector Composition

Rank Sector Weight
1 Healthcare 31.1%
2 Technology 15.04%
3 Communication Services 14.51%
4 Energy 10.4%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$37.1M 11.21%
285,549
AAPL icon
2
Apple
AAPL
$4.67T
$17.8M 5.38%
374,572
+17,908
+5% +$760K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$13.8M 4.17%
233,960
+20
+0% +$1.13K
BX icon
4
Blackstone
BX
$107B
$10.7M 3.25%
307,174
+6,354
+2% +$212K
RTN
5
DELISTED
Raytheon Company
RTN
$10.7M 3.24%
58,825
+18,977
+48% +$3.31M
TMO icon
6
Thermo Fisher Scientific
TMO
$230B
$10.7M 3.22%
38,920
-83
-0.2% -$20.7K
EPD icon
7
Enterprise Products Partners
EPD
$84.3B
$10.2M 3.09%
350,972
+2,946
+0.8% +$82.3K
CI icon
8
Cigna
CI
$73.7B
$10.1M 3.07%
63,010
+15,921
+34% +$2.91M
CSCO icon
9
Cisco
CSCO
$433B
$9.17M 2.77%
169,816
-175
-0.1% -$8.5K
IBB icon
10
iShares Biotechnology ETF
IBB
$10.5B
$8.91M 2.7%
79,727
-754
-0.9% -$82.7K
INTC icon
11
Intel
INTC
$473B
$8.85M 2.68%
164,878
-245
-0.1% -$12.4K
META icon
12
Meta Platforms (Facebook)
META
$1.47T
$8.55M 2.59%
51,266
-262
-0.5% -$41.7K
UNH icon
13
UnitedHealth
UNH
$353B
$8.32M 2.52%
33,637
+30
+0.1% +$7.65K
CMCSA icon
14
Comcast
CMCSA
$96B
$8.15M 2.47%
203,878
-254
-0.1% -$9.56K
MPLX icon
15
MPLX
MPLX
$60.1B
$8.07M 2.44%
245,261
+3,319
+1% +$111K
MPC icon
16
Marathon Petroleum
MPC
$104B
$7.57M 2.29%
+126,494
New +$7.96M
AMAT icon
17
Applied Materials
AMAT
$366B
$7.55M 2.29%
190,461
+137,487
+260% +$5.22M
PFE icon
18
Pfizer
PFE
$159B
$7.33M 2.22%
181,933
-211
-0.1% -$8.45K
UNP icon
19
Union Pacific
UNP
$183B
$7.33M 2.22%
43,820
-100
-0.2% -$16.1K
AMGN icon
20
Amgen
AMGN
$234B
$7.28M 2.2%
38,319
+132
+0.3% +$25.2K
BXMT icon
21
Blackstone Mortgage Trust
BXMT
$2.31B
$6.68M 2.02%
193,367
+5,162
+3% +$175K
DD icon
22
DuPont de Nemours
DD
$18.5B
$6.22M 1.88%
46,113
+214
+0.5% +$29.7K
DHR icon
23
Danaher
DHR
$152B
$6.07M 1.84%
51,887
-271
-0.5% -$27.8K
T icon
24
AT&T
T
$178B
$5.99M 1.81%
252,993
+162
+0.1% +$3.73K
LMT icon
25
Lockheed Martin
LMT
$130B
$4.85M 1.47%
16,168
+924
+6% +$271K

Similar funds

Private Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Private Capital Advisors held 100 positions worth $330M, up 18% from $279M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Private Capital Advisors deployed $20M of net new capital in Q1 2019, opening 10 new positions and adding to 21 existing holdings. Its largest new stake was Marathon Petroleum: 126,494 shares worth $7.57M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Stryker, an estimated $3.09M trimmed.

  • Private Capital Advisors's largest Q1 2019 buy was Marathon Petroleum: 126,494 shares worth $7.57M.
  • Private Capital Advisors added most to Applied Materials in Q1 2019, an estimated $5.22M increase.
  • Private Capital Advisors's biggest Q1 2019 reduction was Stryker, cutting an estimated $3.09M.
  • Private Capital Advisors fully exited Howmet Aerospace in Q1 2019, selling an estimated $3.47M.
  • Private Capital Advisors's ten largest holdings make up 42% of its $330M portfolio in Q1 2019.
  • Private Capital Advisors opened 10 new positions and closed 3 in Q1 2019.
  • Private Capital Advisors's portfolio value rose 18% quarter-over-quarter to $330M.

Based on Private Capital Advisors's 13F filing for Q1 2019, filed 9 Apr 2019.